Alan I. Green, MD
- 9Articles
- 47.5KReads1
- 2005–2020Active
- 38Collaborators
- 87Citations2
About
Alan I. Green, MD, has published extensively on schizophrenia and schizoaffective disorders, with a focus on comorbid substance use disorders. His work includes clinical trials evaluating antipsychotic treatments such as olanzapine plus samidorphan and comparisons between long-acting injectable and oral risperidone. Green has also contributed to research on the relationship between marijuana use and the risk of developing schizophrenia, as well as broader efforts to improve the management of schizophrenia. His publications span from 2005 to 2020 and often involve collaboration with noted researchers in the field.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
